Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Enzo Life Sciences Cytokeratin 1/5/10/14 (human) monoclonal antibody (34betaE12) (Ready-to-Use) (6ml)
SDP

Supplier:  Enzo Life Sciences ENZ30903

Encompass_Preferred

Clone: 34βE12. Isotype: IgG1. Immunogen: Keratin solubilized from human stratum corneum. Source: Purified from ascites. Species reactivity: Human. Specificity: 34βE12 is specific for “high molecular weight” cytokeratins 1, 5, 10 and 14, corresponding to molecular weights 68, 58, 56.5 and 50 kDa, respectively, which are characteristically found in “complex” epithelium. The antibody reacts with all squamous and ductal epithelium as well as carcinomas such as squamous cell carcinoma and adenocarcinoma of ductal origin (e.g., breast, pancreas) but does not react with sarcoma, melanoma or lymphoma. This antibody reacts with benign small-acinar lesions of the prostate and has been shown to be useful as an adjunct in the identification of prostate carcinoma. Applications: IHC (PS), WB. Purity: Affinity purified. Formulation: Liquid. Ready-to-use solution in PBS containing 0.1% sodium azide and 1% BSA.

Catalog No. 50-201-2481


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.